Early Identification of Poorly Performing Implants in Michigan With the Example of the Vanguard XP

Background: Arthroplasty registries play a critical role in improving the quality of care and performing post-market surveillance of medical devices. We report the Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI) findings specific to the Biomet Vanguard XP bicruciate-retainin...

Full description

Saved in:
Bibliographic Details
Main Authors: Nicholas B. Frisch, MD, MBA, Michael A. Masini, MD, Huiyong Zheng, PhD, Richard E. Hughes, PhD, Brian R. Hallstrom, MD, David C. Markel, MD
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Arthroplasty Today
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352344124001638
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850249132603604992
author Nicholas B. Frisch, MD, MBA
Michael A. Masini, MD
Huiyong Zheng, PhD
Richard E. Hughes, PhD
Brian R. Hallstrom, MD
David C. Markel, MD
author_facet Nicholas B. Frisch, MD, MBA
Michael A. Masini, MD
Huiyong Zheng, PhD
Richard E. Hughes, PhD
Brian R. Hallstrom, MD
David C. Markel, MD
author_sort Nicholas B. Frisch, MD, MBA
collection DOAJ
description Background: Arthroplasty registries play a critical role in improving the quality of care and performing post-market surveillance of medical devices. We report the Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI) findings specific to the Biomet Vanguard XP bicruciate-retaining total knee implant. Methods: Data were collected from MARCQI’s 2019 report (February 15, 2012, through December 31, 2018). Demographic data were analyzed to determine differences between Vanguard XP and all other implants. The cumulative percent revision (CPR) was computed from the survival function, S(t), using CPR(t) = 100∗(1 − S(t)). A log-rank test was used to assess differences in the CPR curve for the Vanguard XP and all other implants. Results: There were 148,832 knee arthroplasty cases in the MARCQI registry and 507 using Vanguard XP implant combinations. The unadjusted cumulative percent revision curve up to 5 years postoperatively for the Vanguard XP differed from all other implants (P < .0001). The hazard ratios for the 3 factors included in the Cox proportional hazards model were all significantly different from unity: implant (2.76, 95% CI: 1.98-3.86), sex (0.80, 95% CI: 0.74-0.85), and age (0.96, 95% CI: 0.96-0.97). The top 3 reasons for revision were pain, arthrofibrosis, and aseptic loosening. All surgeons who used the Vanguard XP experienced higher failure rates. Conclusions: The Vanguard XP experienced higher early failure rates than other TKA implants within the MARCQI registry. The development of thresholds and benchmarks for registry reporting in collaboration with industry could potentially save patients from the morbidity caused by implants that do not perform as well as anticipated.
format Article
id doaj-art-afa147db3c88465a9bc796d617cab446
institution OA Journals
issn 2352-3441
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Arthroplasty Today
spelling doaj-art-afa147db3c88465a9bc796d617cab4462025-08-20T01:58:33ZengElsevierArthroplasty Today2352-34412024-12-013010147810.1016/j.artd.2024.101478Early Identification of Poorly Performing Implants in Michigan With the Example of the Vanguard XPNicholas B. Frisch, MD, MBA0Michael A. Masini, MD1Huiyong Zheng, PhD2Richard E. Hughes, PhD3Brian R. Hallstrom, MD4David C. Markel, MD5Ascension Providence Rochester Hospital, Rochester Hills, MI, USA; Corresponding author. Ascension Providence Rochester Hospital, 1135 West University Drive, Suite 450, Rochester, MI 48307, USA. Tel.: +1 248 866 0800.Trinity Health, IHA-Ann Arbor Orthopaedic Surgery, Ypsilanti, MI, USAMARCQI Coordinating Center, University of Michigan, Ann Arbor, MI, USADepartment of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USADepartment of Orthopaedic Surgery, University of Michigan, Ann Arbor, MI, USAThe CORE Institute, Phoenix, AZ, USA; Ascension Providence Hospital, Southfield, MI, USABackground: Arthroplasty registries play a critical role in improving the quality of care and performing post-market surveillance of medical devices. We report the Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI) findings specific to the Biomet Vanguard XP bicruciate-retaining total knee implant. Methods: Data were collected from MARCQI’s 2019 report (February 15, 2012, through December 31, 2018). Demographic data were analyzed to determine differences between Vanguard XP and all other implants. The cumulative percent revision (CPR) was computed from the survival function, S(t), using CPR(t) = 100∗(1 − S(t)). A log-rank test was used to assess differences in the CPR curve for the Vanguard XP and all other implants. Results: There were 148,832 knee arthroplasty cases in the MARCQI registry and 507 using Vanguard XP implant combinations. The unadjusted cumulative percent revision curve up to 5 years postoperatively for the Vanguard XP differed from all other implants (P < .0001). The hazard ratios for the 3 factors included in the Cox proportional hazards model were all significantly different from unity: implant (2.76, 95% CI: 1.98-3.86), sex (0.80, 95% CI: 0.74-0.85), and age (0.96, 95% CI: 0.96-0.97). The top 3 reasons for revision were pain, arthrofibrosis, and aseptic loosening. All surgeons who used the Vanguard XP experienced higher failure rates. Conclusions: The Vanguard XP experienced higher early failure rates than other TKA implants within the MARCQI registry. The development of thresholds and benchmarks for registry reporting in collaboration with industry could potentially save patients from the morbidity caused by implants that do not perform as well as anticipated.http://www.sciencedirect.com/science/article/pii/S2352344124001638Total knee arthroplastyTKABicruciateRegistry
spellingShingle Nicholas B. Frisch, MD, MBA
Michael A. Masini, MD
Huiyong Zheng, PhD
Richard E. Hughes, PhD
Brian R. Hallstrom, MD
David C. Markel, MD
Early Identification of Poorly Performing Implants in Michigan With the Example of the Vanguard XP
Arthroplasty Today
Total knee arthroplasty
TKA
Bicruciate
Registry
title Early Identification of Poorly Performing Implants in Michigan With the Example of the Vanguard XP
title_full Early Identification of Poorly Performing Implants in Michigan With the Example of the Vanguard XP
title_fullStr Early Identification of Poorly Performing Implants in Michigan With the Example of the Vanguard XP
title_full_unstemmed Early Identification of Poorly Performing Implants in Michigan With the Example of the Vanguard XP
title_short Early Identification of Poorly Performing Implants in Michigan With the Example of the Vanguard XP
title_sort early identification of poorly performing implants in michigan with the example of the vanguard xp
topic Total knee arthroplasty
TKA
Bicruciate
Registry
url http://www.sciencedirect.com/science/article/pii/S2352344124001638
work_keys_str_mv AT nicholasbfrischmdmba earlyidentificationofpoorlyperformingimplantsinmichiganwiththeexampleofthevanguardxp
AT michaelamasinimd earlyidentificationofpoorlyperformingimplantsinmichiganwiththeexampleofthevanguardxp
AT huiyongzhengphd earlyidentificationofpoorlyperformingimplantsinmichiganwiththeexampleofthevanguardxp
AT richardehughesphd earlyidentificationofpoorlyperformingimplantsinmichiganwiththeexampleofthevanguardxp
AT brianrhallstrommd earlyidentificationofpoorlyperformingimplantsinmichiganwiththeexampleofthevanguardxp
AT davidcmarkelmd earlyidentificationofpoorlyperformingimplantsinmichiganwiththeexampleofthevanguardxp